Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population
- 1 May 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (8) , 1164-1169
- https://doi.org/10.1016/j.ejca.2005.01.017
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Vitamin D Receptor Gene Polymorphisms and Breast Cancer RiskClinical Cancer Research, 2004
- Analysis of the Vitamin D System in Cervical Carcinomas, Breast Cancer and Ovarian CancerPublished by Springer Nature ,2003
- Association of Vitamin D Receptor Gene Polymorphism with Renal Cell Carcinoma in Japanese.Endocrine Journal, 2002
- Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian populationBritish Journal of Cancer, 2001
- 25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesisSteroids, 2001
- Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States)Cancer Causes & Control, 2001
- Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesisFrontiers in Bioscience-Landmark, 2001
- Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D AnalogsCurrent Pharmaceutical Design, 2000
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiationPreventive Medicine, 1990